Hap Trading, LLC Amicus Therapeutics, Inc. Put Options Transaction History

Hap Trading, LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2021 Aug 11, 2021	SELL	$8.71 - $10.72 $278,720 - $343,040	-32,000 Reduced 58.18%	23,000 $27,000
Q1 2021 May 14, 2021	SELL	$9.2 - $23.86 $2.11 Million - $5.47 Million	-229,300 Reduced 80.65%	55,000 $471,000
Q4 2020 Feb 16, 2021	BUY	$13.47 - $24.89 $3.83 Million - $7.08 Million	284,300 New	284,300 $304,000
Q2 2019 Aug 14, 2019	SELL	$10.96 - $14.4 $278,384 - $365,760	-25,400 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$10.04 - $13.92 $55,219 - $76,560	5,500 Added 27.64%	25,400 $1,000
Q1 2018 May 11, 2018	SELL	$13.76 - $17.12 $1.9 Million - $2.36 Million	-138,100 Reduced 87.41%	19,900 $3,000
Q3 2017 Nov 08, 2017	BUY	$11.74 - $15.78 $1.85 Million - $2.49 Million	158,000	158,000 $20,000

311

312M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.7B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.